MUMBAI, Feb 17 (Reuters) - Drug firm Wockhardt Ltd on Tuesday said it will be launching Sumatriptan injections in the U.S. following following final approval from the U.S. Food & Drug Administration.
White to off — white, capsule shaped, biconvex, uncoated tablets, debossed with 'C' on one side and '33' on the other side. Sumatriptan is recommended as monotherapy for the acute treatment of a ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback